- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05333016
A Dyadic Approach to Cancer Care: a Feasibility and Efficacy Partner-based Exercise Study (C4C)
Study Overview
Detailed Description
NEED: Cancer has been characterized as a family affair, as it is a disease in which both the patient and their family members are confronted by considerable physical and psychological stressors. With an anticipated 80% increase in the average number of new cancer diagnoses by 2030 and rapidly escalating health care costs, there has been a shift to outpatient and home-based care. In doing so, family members are increasingly being called upon to participate as informal caregivers (i.e., an individual who provided uncompensated care). Despite being a key partner in the supportive care of the cancer patient, family caregivers are often inadequately prepared or supported to take on this critical role, subsequently putting their own health and well-being at risk and by extension, that of the cancer patient/survivor. Preliminary data suggests that exercise interventions show promise in mitigating caregiver burden and improving health outcomes for both the caregiver and the patient/survivor. To date, however only two studies have examined the benefit of exercise interventions on family caregiver and patient outcomes within the cancer care context.
GOAL: The primary goal of this study will be to assess the feasibility and acceptability of a partner-based 12-week exercise intervention. The investigators will also explore the preliminary effectiveness of the exercise program on caregiver burden and physical and psychological health of both the family caregiver and the care recipient.
WHO: Participants will include adult primary caregivers and cancer patients/survivors of all cancers and stages at any point along the cancer care trajectory.
HOW: Using both surveys and participant interviews, the participant experience and impact (e.g., physical and psychological health benefits) of a 12-week, partner-based exercise intervention will be evaluated. The 12-week exercise program will include a combination of aerobic, resistance, balance, and flexibility exercises delivered in a partner-based setting twice weekly at a dedicated cancer and exercise lab.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 2Y9
- Physical Activity and Cancer (PAC) Lab
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria (all):
- 18+ years
- able to perform discontinuous low intensity physical activity at a minimum
- able to provide informed written consent in English.
Inclusion Criteria (cancer patients/survivors)
- are along any stage of the cancer continuum (i.e., pre-treatment, receiving active treatment, and up to 5 years post-treatment)
Inclusion Criteria (informal caregivers)
- must be currently providing physical and/or psychological support to an adult (+18 years) cancer patient/survivor
- not be exceeding current Canadian physical activity guidelines (i.e., 150 minutes of moderate-to-vigorous physical activity per week)
Exclusion Criteria (all):
- Patients/survivors and caregivers will be excluded from the study if they have any medical conditions that would contraindicate exercise
Exclusion Criteria (informal caregivers)
- Bereaved caregivers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Multimodal Exercise Intervention
12-week, twice weekly partner-based multimodal exercise program
|
Multimodal exercise programming including aerobic, resistance, balance, and flexibility exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment
Time Frame: Through study completion, about 2 years
|
Participant accrual as defined as the number of eligible participant dyads who consents to participate
|
Through study completion, about 2 years
|
|
Intervention Adherence
Time Frame: Through study completion, about 2 years
|
Participant program adherence calculated as percentage of exercise sessions completed divided by total number of available exercise sessions over 12-week intervention
|
Through study completion, about 2 years
|
|
Adverse Events
Time Frame: Through study completion, about 2 years
|
Adverse and serious adverse events will be recorded
|
Through study completion, about 2 years
|
|
Attrition
Time Frame: Through study completion, about 2 years
|
Participant attrition calculated as percentage of patients who complete 12-week study divided by number who withdraw from study
|
Through study completion, about 2 years
|
|
Participant Satisfaction
Time Frame: Post intervention, about 12-weeks after baseline
|
Participant satisfaction will be assessed by semi-structured interviews (no min/max)
|
Post intervention, about 12-weeks after baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver Burden
Time Frame: Pre to post intervention (12-week change)
|
Assessed by the 22-item Zarit Burden Interview (ZBI).
Responses are scored on a 5-point Likert scale ranging from 0 (never) to 4 (nearly always) with the sum of scores ranging from 0 to 88 (higher scores indicate higher burden)
|
Pre to post intervention (12-week change)
|
|
Body Mass Index (BMI)
Time Frame: Pre to post intervention (12-week change)
|
Weight (kg) and height (m) will be used to calculate BMI
|
Pre to post intervention (12-week change)
|
|
Body Composition
Time Frame: Pre to post intervention (12-week change)
|
Waist and hip circumference
|
Pre to post intervention (12-week change)
|
|
Resting heart rate
Time Frame: Pre to post intervention (12-week change)
|
Resting heart rate
|
Pre to post intervention (12-week change)
|
|
Resting Blood Pressure
Time Frame: Pre to post intervention (12-week change)
|
Resting systolic and diastolic blood pressure
|
Pre to post intervention (12-week change)
|
|
Aerobic Fitness
Time Frame: Pre to post intervention (12-week change)
|
The 6-minute walk test will be used to assess aerobic capacity
|
Pre to post intervention (12-week change)
|
|
Upper Body Strength
Time Frame: Pre to post intervention (12-week change)
|
Grip strength will be measured using a hand-held dynamometer
|
Pre to post intervention (12-week change)
|
|
Muscular Endurance
Time Frame: Pre to post intervention (12-week change)
|
Lower body muscular endurance will be assessed using the 30-second sit-to-stand
|
Pre to post intervention (12-week change)
|
|
Balance
Time Frame: Pre to post intervention (12-week change)
|
Balance will be assessed using the one-legged stance
|
Pre to post intervention (12-week change)
|
|
Flexibility
Time Frame: Pre to post intervention (12-week change)
|
Flexibility will be assessed using the sit-and-reach and shoulder flexibility
|
Pre to post intervention (12-week change)
|
|
Caregiver Quality of Life
Time Frame: Pre to post intervention (12-week change)
|
Quality of life will be assessed using the Short-Form Health Survey- SF-36.
The SF-36 consists of 36 questions that cover 8 health domains/subscales (physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health).
The total scale score ranges from 0 to 100 with higher values representing higher quality of life.
|
Pre to post intervention (12-week change)
|
|
Cancer Patient Quality of Life
Time Frame: Pre to post intervention (12-week change)
|
Quality of life for cancer patients will be assessed using the Functional Assessment of Cancer Therapy - General survey.
The combined 27-item scale provides subscale scores physical (7-items), functional (7-items), emotional (6-items), and social/family (7-items) well-being.
The sum of scores on the five domains evaluates a participants' quality of life with higher scores (ranging from 0-108) denoting higher quality of life.
|
Pre to post intervention (12-week change)
|
|
Cancer Patient Fatigue
Time Frame: Pre to post intervention (12-week change)
|
Fatigue will be assessed using the 13-item Functional Assessment of Chronic Illness Therapy - Fatigue survey.
Scores range from 0-52 with higher scores indicating better functioning/less fatigue
|
Pre to post intervention (12-week change)
|
|
Self-Reported Physical Activity
Time Frame: Pre to post intervention (12-week change)
|
Physical activity will be assessed using the Godin Leisure Time Exercise Questionnaire.
Total score ranges from 0 to no maximum.
|
Pre to post intervention (12-week change)
|
|
General Health (EuroQol) 5 Dimension - 5 Level
Time Frame: Pre to post intervention (12-week change)
|
Mobility, self-care, usual activities, pain/discomfort, anxiety/depression (EuroQol-5Dimension-5Level; EQ-5D-5L); higher scores indicate higher problems (range 0-1)
|
Pre to post intervention (12-week change)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Melanie Keats, PhD, Dalhousie University / Nova Scotia Health
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NSH Caring 4 Cancer Caregivers
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
UNICANCERRecruitingAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)France
Clinical Trials on Multimodal exercise
-
University of ÉvoraFoundation for Science and Technology, Portugal; Comprehensive Health Research...Completed
-
Istanbul University - CerrahpasaBezmialem Vakif University; Acıbadem Atunizade HospitalNot yet recruiting
-
National Cheng Kung UniversityCompleted
-
Hospices Civils de LyonCompletedPhysical Activity | GerontologyFrance
-
University of ÉvoraSão João de Deus School of Nursing; Horizon 2020 - Portugal 2020 (ALT20-03-0145-FEDER-000007...CompletedCommunity-dwelling Older AdultsPortugal
-
Chang Gung Memorial HospitalCompletedElderly ExerciseTaiwan
-
German Cancer Research CenterUniversity of Leipzig; Heidelberg University; University Hospital Heidelberg; Children...CompletedChildhood CancerGermany
-
State University of LondrinaNot yet recruiting
-
yueh chu wuRecruitingType 2 Diabetes Mellitus (T2DM)Taiwan
-
Consorci Sanitari de TerrassaCompleted